Stay updated on Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.4 to v3.6.5, representing a newer version of the site template or page metadata.
    Difference
    0.0%
    Check dated 2026-08-11T19:27:39.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision updated from v3.6.3 to v3.6.4 on the page, reflecting a new version of the page metadata. This indicates a minor update to the page rather than changes to the study details or content.
    Difference
    0.0%
    Check dated 2026-07-21T12:36:12.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.0 to v3.6.3. This reflects a minor update to the page’s revision history.
    Difference
    0.0%
    Check dated 2026-06-30T00:49:23.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Added recruitment status text 'No longer looking for participants' and new guidance sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') along with a new 'Intervention/Treatment' heading (replacing 'Intervention / Treatment'). The page revision was updated to v3.6.0, replacing v3.5.5.
    Difference
    0.1%
    Check dated 2026-06-15T18:48:03.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The change updates the document revision log to v3.5.5 and removes the previous v3.5.4, indicating a newer version of the study documentation has been published.
    Difference
    0.0%
    Check dated 2026-06-08T16:17:18.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The page now includes a more detailed ORR definition evaluated by IRRC using RECIST v1.1 for intermediate/poor-risk patients, with associated time frames, and adds PDFs for the Study Protocol, Protocol Amendment 06, and the Statistical Analysis Plan; the previous Investigator-assessed ORR description and its time frame were removed.
    Difference
    0.3%
    Check dated 2026-06-01T12:43:03.000Z thumbnail image

Stay in the know with updates to Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab-Ipilimumab vs Sunitinib in Advanced RCC Clinical Trial page.